Close
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan Jun 2, 2024 08:56AM

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- To address the increasing need for real-time AI computing at the industrial edge, NVIDIA today announced the general software availability of NVIDIA AI Enterprise-IGX with NVIDIA Holoscan on the NVIDIA IGX™ platform. Together, they empower solution providers within the medical, industrial and scientific computing sectors to develop and deploy edge AI solutions faster, with enterprise-grade software and... (continue reading...)


NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autonomous Machines Jun 2, 2024 08:52AM

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced that the world’s leaders in robot development are adopting the NVIDIA Isaac™ robotics platform for the research, development and production of the next generation of AI-enabled autonomous machines and robots.

BYD Electronics, Siemens, Teradyne Robotics and Intrinsic, an Alphabet company, are among more than a dozen robotics industry leaders globally that are integrating NVIDIA... (continue reading...)


Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and Omniverse Jun 2, 2024 08:44AM

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced that major Taiwanese electronics makers are using the company’s technology to transform their factories into more autonomous facilities with a new reference workflow. The workflow combines NVIDIA Metropolis vision AI, NVIDIA Omniverse™ physically based rendering and simulation, and NVIDIA Isaac™ AI robot development and deployment.

By using the workflow to build digital twins... (continue reading...)


Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Jun 2, 2024 08:42AM

GUANGZHOU, China, June 2, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, will present a poster at the 2024 ASCO Annual Meeting entitled "Phase 1 study of BAT8006, a folate receptor α antibody drug conjugate with strong bystander effect, in subjects with advanced solid tumors," that highlights clinical data for the potential best-in-class efficacy... (continue reading...)


NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs Jun 2, 2024 08:41AM

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced new NVIDIA RTX™ technology to power AI assistants and digital humans running on new GeForce RTX™ AI laptops.

NVIDIA unveiled Project G-Assist — an RTX-powered AI assistant technology demo that provides context-aware help for PC games and apps. The Project G-Assist tech demo debuted with ARK: Survival Ascended from Studio Wildcard. NVIDIA also introduced the first PC-based... (continue reading...)


More Press Releases

View Older Stories

Jun 2, 2024 08:35AM Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolution
Jun 2, 2024 08:32AM NVIDIA Supercharges Ethernet Networking for Generative AI
Jun 2, 2024 08:30AM Trend Micro to Secure AI-Enabled Private Data Centers Worldwide
Jun 2, 2024 08:30AM Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
Jun 2, 2024 08:30AM Vention to democratize industrial automation using NVIDIA AI technologies
Jun 2, 2024 08:30AM Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
Jun 2, 2024 08:23AM GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Jun 2, 2024 08:13AM NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI Developers
Jun 2, 2024 08:11AM NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars
Jun 2, 2024 08:05AM IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
Jun 2, 2024 08:00AM ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
Jun 2, 2024 08:00AM ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lin
Jun 2, 2024 08:00AM OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
Jun 2, 2024 08:00AM Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the Unit
Jun 2, 2024 08:00AM Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
Jun 2, 2024 08:00AM Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
Jun 2, 2024 08:00AM William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
Jun 2, 2024 08:00AM CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
Jun 2, 2024 07:00AM RentFinder.ai Sets New Standards in Rental Estimates, Achieves 250% Surge in Usage
Jun 2, 2024 07:00AM Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
Jun 2, 2024 07:00AM June Joy at Juicy Stakes Casino
Jun 2, 2024 07:34AM Accelerate Your Establishment Forward By Implementing These Simple Corporate Hacks
Jun 2, 2024 07:34AM Exploring The Main Aspects To Consider When Eradicating Pesky Pests From Your Home
Jun 2, 2024 06:18AM Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Jun 2, 2024 06:37AM Top 10 Compelling Reasons Why Your Kids Should Have Regular School Physicals
Jun 2, 2024 06:23AM Odyssey Capital participated in the Washington D.C. Blockchain Summit, proposing the establishment of a Global Special Assets Alliance Fund initiative.
Jun 2, 2024 06:15AM Are Ruby Gemstones Worth Investing In?
Jun 2, 2024 04:00AM BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
Jun 2, 2024 03:39AM Capsucup: Where Quality and Sustainability Meet in Italian Espresso
Jun 2, 2024 03:23AM Leading Contractor Marketing Agency Webrunner Media Broadens Service Portfolio
Jun 2, 2024 03:21AM Xfive Recognized as a Clutch Global Leader for Spring 2024
Jun 2, 2024 02:00AM ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
Jun 2, 2024 01:13AM Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
Jun 2, 2024 12:57AM Eyes Defined Introduces 3D Images to Revolutionize Eyelid Surgery Planning
Jun 1, 2024 11:56PM Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
Jun 1, 2024 09:00PM BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
Jun 1, 2024 08:25PM Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
Jun 1, 2024 08:24PM OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaka' at the UEFA Champions League Final 2024
Jun 1, 2024 08:17PM CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
Jun 1, 2024 08:15PM OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaká at the UEFA Champions League Final 2024
Jun 1, 2024 08:15PM Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever
Jun 1, 2024 08:00PM Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
Jun 1, 2024 08:00PM Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00PM Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
Jun 1, 2024 07:13PM GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a La
Jun 1, 2024 06:09PM LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Jun 1, 2024 05:52PM Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
Jun 1, 2024 05:10PM National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec
Jun 1, 2024 04:30PM Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
Jun 1, 2024 03:40PM BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
View Older Stories